US kidney failure rates stabilize, ending a 20-year climbOctober 11, 2005After 20 years of annual increases from 5 to 10 percent, rates for new cases of kidney failure have stabilized, according to new research from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health. At the same time, dramatic racial disparities persist. In 2003, the rate for new cases of kidney failure was 338 per million population, down slightly from 2002 and continuing a four-year trend, finally allowing researchers to be cautiously optimistic that rate decreases have not happened by chance. The average annual increase has been less than 1 percent since 1999, compared to an average 5 percent in the previous decade, according to research published recently by NIDDK's U.S. Renal Data System (USRDS) at www.usrds.org and being presented next month at the annual scientific meeting of the American Society of Nephrology. Diabetes and high blood pressure remain the leading causes of kidney failure, accounting for 44 percent and 28 percent of all new cases, respectively. The most striking trends were found in diabetes, where rates for new cases in whites under age 40 were the lowest since the late 1980's, in stark contrast to rates for their African American counterparts, which have not budged. "It's gratifying to see progress, however small, and to know that NIDDK activities undoubtedly have had a hand in that success," said Paul W. Eggers Ph.D., NIDDK's co-director for the USRDS. "But persistent disparities are sobering." Credit for recent gains likely goes to clinical strategies proven in the 1990s to significantly delay or prevent kidney failure: angiotensin-converting enzyme inhibitors (ACE-inhibitors) and angiotensin receptor blockers (ARBs), which lower protein in the urine and are thought to directly prevent injury to the kidneys' blood vessels; and careful control of diabetes and blood pressure. The launch of private and government programs to improve care and increase awareness coincided with these developments, including NIDDK's National Kidney Disease Education Program (NKDEP). NKDEP encourages early diagnosis and management by increasing awareness about: the connection between diabetes, high blood pressure and kidney disease strategies proven to prevent or delay kidney failure estimating kidney function (eGFR) to find kidney disease earlier efforts to standardize testing for kidney disease and encourage more labs to automatically report eGFR, and * time-saving tools for health professionals at www.nkdep.nih.gov, including eGFR calculators that eliminate most of the work to estimate kidney function; and a letter template, which automatically calculates patient-specific eGFR, generates a list of next steps based on kidney disease stage and is designed to improve communication between kidney specialists and primary care physicians. Despite incremental successes in preventing kidney failure and in improving health and survival of people who have it already, the increasing and aging U.S. population means that more people than ever before are getting and living with the disease. In 2003, nearly 537,000 people received dialysis or a kidney transplant. The cost to Medicare was $18.1 billion, with another $9.2 billion borne by private insurers and patients. Another 10 million people in the United States have earlier kidney disease; most don't know they have it, let alone that the disease increases the risk for premature death, heart attacks, strokes, and other problems. The research also found both encouraging and discouraging news about the quality of care for people with chronic kidney disease (CKD), an earlier stage that precedes kidney failure. Tests to find kidney disease at the earliest, most-treatable stages are not widely used. Only 10 percent of the general Medicare population had a blood test and only 5 percent had urine tested for kidney disease. But, while ACE-inhibitors and ARBs are still underutilized, there has been a dramatic increase in their use. In the past decade, the use of these drugs doubled among people over age 60 with CKD, from 16 percent to 32 percent of patients, and nearly half of those who also had diabetes or hypertension or congestive heart failure used them. "We could prevent or delay a lot more kidney failure, simply by using the box of tools that are already in the trunk," said Josephine P. Briggs, M.D., a kidney specialist and director of NIDDK's Division of Kidney, Urologic, and Hematologic Diseases. NIH/National Institute of Diabetes and Digestive a |
|||||||||||||||||||||
| Related Kidney Failure Current Events and Kidney Failure News Articles Key player identified in cascade that leads to hypertension-related kidney damage A key player in a cascade that likely begins with stress and leads to high blood pressure and kidney damage has been identified by researchers who say the finding may lead to better ways to control both. Kidney transplants generally safe for lupus patients Individuals with a history of lupus who receive a kidney transplant rarely develop the serious inflammatory condition lupus nephritis in their new organ, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. A decade later, lifestyle changes or metformin still lower type 2 diabetes risk Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent compared with placebo in people at high risk for the disease, researchers conclude based on 10 years of data. Calculate benefit before dialysis for frail elders Kidney specialists should weigh the potential quality of life for frail elders with end-stage renal disease (ESRD) in opting for dialysis over more conservative therapies, a nephrologist and a palliative care specialist suggest in an editorial in the New England Journal of Medicine. Study questions need for routine intervention in patients with renovascular disease Some invasive procedures that are becoming increasingly common as a first line of treatment for patients diagnosed with narrowed arteries in and around the kidneys may not be necessary. Ironing out the genetic cause of hemoglobin problems A gene with a significant effect on regulating hemoglobin in the body has been identified as part of a genome-wide association study, which looked at the link between genes and hemoglobin level in 16,000 people. National report shines light on lupus 50-year treatment drought Today, The Lewin Group, a national health care consulting firm, issued recommendations on ways to overcome the barriers that have obstructed lupus drug development resulting in no new drug approval for this disease in more than 50 years - since the Eisenhower Administration. Kidneys from deceased donors with acute renal failure expand donor pool Kidneys recovered from deceased donors with acute renal failure (ARF) - once deemed unusable for transplant - appear to work just as well as kidneys transplanted from deceased donors who do not develop kidney problems prior to organ donation. Study details safe, effective, minimally invasive mitral valve repair Surgical treatment for mitral valve disease includes either repairing the patient's diseased valve or replacing it with a metal, mechanical valve or an animal tissue valve. Rare genetic disease successfully reversed using stem cell transplantation A recent study by Scripps Research Institute scientists offers good news for families of children afflicted with the rare genetic disorder, cystinosis. More Kidney Failure Current Events and Kidney Failure News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||